natgillin/translations-raw huggingface dataset:
If you are receiving dialysis treatment when you begin treatment with Retacrit, your dialysis regimen may need to be adjusted to maintain urea, creatinine and potassium levels in the desired range.
Če ste ob začetku zdravljenja z zdravilom Retacrit na dializi, bo mogoče treba popraviti Vaš urnik na dializi, da sečnina, kreatinin in kalij ostanejo v želenih mejah.
Your doctor will decide this.
O tem bo odločil Vaš zdravnik.
Serum electrolytes (substances in your blood) should be monitored in chronic renal failure patients.
Pri bolnikih s kronično ledvično odpovedjo je treba meriti elektrolite v serumu (snovi v krvi).
If an elevated (or rising) serum potassium level is detected, your doctor may consider to stop the treatment with Retacrit until the level is back to normal.
Če se med zdravljenjem pojavi povečana koncentracija kalija ali njeno naraščanje, moramo premisliti o prekinitvi, do vrnitve na normalne vrednosti.
Cancer patients Cancer patients are more likely to suffer from blood clots if receiving erythropoietin medicines, like Retacrit (see section 4).
Bolniki z rakom Pri bolniki z rakom, ki prejemajo zdravila z eritropoetinom, kot je zdravilo Retacrit, se bolj pogosto pojavijo krvni strdki (glej poglavje 4).
Therefore, you should discuss the benefits of Retacrit with your doctor, particularly if you are obese or have a history of blood clots/blood clotting disorders.
Zato se morate o koristih zdravila Retacrit pogovoriti s svojim zdravnikom, posebno če ste debeli ali če ste že imeli krvne strdke ali motnje strjevanja krvi.
If you are a cancer patient, you should be aware that Retacrit, may act as a blood cell growth factor and in some circumstances may have a negative impact on your cancer.
Če imate raka, se morate zavedati, da lahko zdravilo Retacrit deluje kot rastni faktor za krvne celice in v nekaterih primerih negativno vpliva na vašo bolezen.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Povejte svojemu zdravniku ali farmacevtu, če jemljete ali ste pred kratkim jemali katerokoli zdravilo, tudi če ste ga dobili brez recepta.
In particular, if you are taking a medicine containing the active substance ciclosporin to suppress your immune system after a kidney transplant, your doctor may order special blood tests to measure ciclosporin levels while you are taking Retacrit.
V primeru, da jemljete zdravilo, ki vsebuje zdravilno učinkovino ciklosporin, s katerim se po transplantaciji ledvic zavira imunaki sistem, Vam bo zdravnik morda predpisal posebno teste krvi, s katerimi se med jemanjem zdravila Retacrit meri koncentracija ciklosporina.
186 Pregnancy and breast-feeding
197 Nosečnost in dojenje
Tell your doctor if you are pregnant or think you may be pregnant or are breast-feeding.
Povejte svojemu zdravniku, če ste noseči ali če mislite, da ste noseči, in pa če dojite.
Ask your doctor for advice before taking any medicine.
Preden vzamete katerokoli zdravilo, se posvetujte s svojim zdravnikom.
Retacrit has no or negligible effect on the ability to drive and use machines.
Zdravilo Retacrit nima oziroma ima zanemarljiv vpliv na sposobnost za vožnjo in upravljanje s stroji.
Important information about some of the ingredients of Retacrit
Pomembna informacija o nekaterih sestavinah zdravila Retacrit
This medicine contains phenylalanine and may be harmful for people with phenylketonuria.
To zdravilo vsebuje fenilalanin, ki lahko škoduje ljudem s fenilketonurijo.
HOW TO USE RETACRIT
KAKO UPORABLJATI ZDRAVILO RETACRIT
Always use Retacrit exactly as your doctor has told you.
Zdravilo Retacrit uporabljajte vedno natančno tako, kot Vam je rekel zdravnik.
Dosage information
Podatki o odmerku
The dose you receive is based on your body weight in kilograms.
Odmerek, ki ga dobivate, temelji na Vaši telesni masi v kilogramih.
Your doctor will conduct investigations, for example blood tests, to help decide if it is necessary for you to have Retacrit.
Vaš zdravnik bo naročil preiskave, na primer krvne test, ki mu pomagajo odločiti, ali potrebujete zdravilo Retacrit.
He/she will work out the correct dose of Retacrit for you to use, how long the treatment should continue and by what route the medicine will be given.
Določil( a) bo pravilni odmerek zdravila Retacrit za Vas, kako dolgo bo zdravljenje trajalo in na kakšen način boste zdravilo prejemali.
These decisions will be influenced by what is causing your anaemia.
Na te odločitve bo vplival vzrok Vaše anemije.
Use in adult patients receiving haemodialysis Your doctor will maintain your haemoglobin concentration between 10 and 12 g/dl (6.2 - 7.5 mmol/l).
Uporaba pri odraslih bolniki na hemodializi Vaš zdravnik bo vašo koncentracijo hemoglobina ohranjal na vrednosti med 10 in 12 g/ dl (6, 2 – 7, 5 mmol/ l).
The usual starting dose of Retacrit is 50 IU/kg (International Units per kilogram).
Običajni začetni odmerek je 50 i. e. / kg (mednarodnih enot na kilogram).
This is given 3 times a week by injection into a vein (intravenous injection over 1-2 minutes).
Daje se trikrat tedensko kot injekcijo v veno (intravenska injekcija v času 1 do 2 minute).
The dose you receive should not normally exceed 200 IU/kg 3 times a week, and should be given by injection into a vein or a tube that goes into a vein.
Običajno odmerek, ki ga boste dobivali, ne bi smel presegati 200 i. e. / kg trikrat tedensko, dajalo pa se ga bo v obliki injekcije v veno ali v cevko, ki vodi v veno.
When your condition has been brought under control, you will receive regular doses of Retacrit, 2 or 3 times a week.
Ko je Vaše stanje pod nadzorom, boste dvakrat ali trikrat na teden dobivali običajne odmerke zdravila Retacrit.
Use in children and adolescents up to 18 years receiving haemodialysis In children the doctor will maintain the haemoglobin concentration between 9.5 and 11 g/dl
Uporaba pri otrocih in mladostnikih do 18 leta na hemodializi Zdravnik bo koncentracijo hemoglobina pri otrocih vzdrževal med 9, 5 in 11 g/ dl.
Retacrit should be given after the patient has received a dialysis session.
198 Zdravilo Retacrit se daje po dializi.
187 The dose for children and adolescents is based on body weight in kilograms.
Odmerek za otroke in mladostnike temelji na telesni masi v kilogramih.
The usual starting dose is 50 IU/kg.
Običajni začetni odmerek je 50 i. e. / kg.
This is given three times a week, injected into a vein (over 1-2 minutes).
Daje se trikrat tedensko kot injekcijo v veno (v času 1- 2 minuti).
Your doctor will order regular blood tests to see that this is being achieved.
Vaš zdravnik bo redno opravljal preiskave krvi, da preveri, če Vaše zdravilo še naprej pravilno učinkuje..
Use in adult patients receiving peritoneal dialysis Your doctor will maintain your haemoglobin concentration between 10 and 12 g/dl.
Uporaba pri odraslih bolnikihna peritonealni dializi Vaš zdravnik bo vašo koncentracijo hemoglobina ohranjal na vrednosti med 10 in 12 g/ dl.
This is given twice a week by injection into a vein or a tube that goes into a vein.
Daje se dvakrat tedensko v veno ali v cevko, ki vodi v veno.
The total weekly dose that you receive should not normally exceed 200 IU/kg and should be given by injection into a vein or a tube that goes into a vein.
Običajni celotni tedenski odmerek, ki ga boste dobivali, ne bi smel presegati 200 i. e. / kg trikrat tedensko, dajalo pa se ga bo v obliki injekcije v veno ali v cevko, ki vodi v vedo.
The usual starting dose is 50 IU/kg.
Uporaba pri odraslih bolnikih z boleznijo ledvic, ki niso na dializi Običajni začetni odmerek je 50 i. e. / kg.
This is given 3 times a week by injection into a vein or a tube that goes into a vein.
Daje se trikrat tedensko v veno ali v cevko, ki vodi v veno.
After your condition has been brought under control, you will receive regular doses of Retacrit, 3 times a week.
Ko je Vaše stanje pod nadzorom, boste trikrat na teden dobivali običajni odmerek zdravila Retacrit.
The dosage should not normally exceed 200 IU/kg, 3 times a week and should be given by injection into a vein or a tube that goes into a vein.
Običajno odmerek, ki ga boste dobivali, ne bi smel presegati 200 i. e. / kg trikrat tedensko, dajalo pa se ga bo v obliki injekcije v veno ali v cevko, ki vodi v vedno.
Use in adult patients receiving chemotherapy Your doctor may initiate treatment with Retacrit if your haemoglobin level is 10 g/dl or less.
Uporaba pri odraslih bolniki na kemoterapiji Vaš zdravnik lahko uvede zdravljenje z zdravilom Retacrit, če znaša vaša koncentracija hemoglobina 10 g/ dl ali manj.
After initiation of therapy, your doctor will maintain your haemoglobin level between 10 and 12 g/dl
Vaš zdravnik bo po uvedbi terapije ohranjal vašo raven hemoglobina med 10 in 12 g/ dl.
The usual starting dose is 150 IU/kg.
Običajni začetni odmerek je 150 i. e. / kg.
Alternatively, your doctor may recommend a starting dose of 450 IU/kg once a week.
Zdravnik lahko priporoči tudi začetni odmerek 450 i. e. / kg enkrat tedensko.
The starting dose may be adjusted by your doctor depending on how your anaemia responds to treatment; you will usually receive Retacrit until 1 month after the end of chemotherapy.
Običajno dobivate zdravilo Retacrit še en mesec po zaključku kemoterapije.
Use in adult patients in an autologous predonation programme The usual starting dose is 600 IU/kg.
Odrasli kirurški bolniki v programu darovanja avtologne krvi Običajni začetni odmerek je 600 i. e. / kg.
If Retacrit is injected under the skin for anaemia not associated with kidney disease the amount injected in any one place should not exceed 1 ml.
Če si zdravilo Retacrit injicirate pod kožo za anemija, ki je povezana z boleznijo ledvic, se na enem mestu ne sme injicirati več kot 1 ml.
Always follow these instructions when using Retacrit:
199 Kadar uporabljate zdravilo Retacrit, se vedno držite teh navodil:
Inject the solution as you have been shown by your doctor.
Raztopino injicirajte tako, kot Vam je pokazal zdravnik.
• the blister sealing is broken or the blister is damaged in any way • the liquid is coloured or you can see particles floating in it • any liquid has leaked out of the pre-filled syringe or condensation is visible within the sealed blister • you know or think it may have been accidentally frozen
Zdravila Retacrit se ne sme uporabljati, • če je pečat na ovojnini pretrgan ali če je ovojnina na kakršenkoli način poškodovana • če je tekočina obarvana ali če je videti v njej plavati delce • če je iz vnaprej napolnjene brizge iztekla tekočina ali če je v zavarjenem blistru videti kondenzacijo. • če je bila po nesreči zamrznjena
Changing from injecting into a vein to injecting under the skin (from intravenous into subcutaneous injection) Once your condition is controlled you will receive regular doses of Retacrit.
200 Menjava med injiciranjem v žilo in pod kožo (med intravenskim in subkutanim injiciranjem) Ko bo Vaše stanje pod nadzorom, boste začeli dobivati običajne odmerke zdravila Retacrit.
If your anaemia is not associated with kidney disease, your doctor may decide that it is better for you to receive Retacrit by injection under the skin (subcutaneous) rather than into a vein (intravenous).
V kolikor anemija ni povezana z boleznijo ledvic, bo Vaš zdravnik odločil, ali je za Vas bolje, če zdravilo Retacrit dobivate s subkutano (subkutano) injekcijo ali z injekcijo v veno (intravensko).
Afterwards, your doctor may order blood tests to see if any adjustment in dose is required.
Kasneje bo zdravnik morda naročil teste krvi, da vidi, če je treba prilagoditi odmerek.
Injecting Retacrit under the skin yourself for anaemia not associated with kidney disease At the start of your therapy, Retacrit is injected by medical or nursing staff.
Kako si sami injicirate zdravilo Retacrit pod kožo pri anemiji, ki ni povezana z boleznijo ledvic Ob začetku Vaše terapije Vam bodo zdravilo Retacrit injicirali medicinske sestre ali zdravnik.
However, your doctor may decide that it is right for you to learn how to inject Retacrit under the skin (subcutaneously) yourself.
Lahko pa se bo zdravnik odločil, da se lahko naučite, kako si zdravilo Retacrit pod kožo (subkutano) injicirate sami.
You will receive appropriate training to enable you to do this.
V ta namen Vas bodo primerno izobrazili.
Under no circumstances should you attempt to inject yourself unless you have been trained to do so.
Če Vas v ta namen niso izobrazili, si v nobenem primeru zdravila ne poskušajte injicirati sami.
If you use more Retacrit than you should
Če ste uporabili večji odmerek zdravila Retacrit, kot bi smeli:
You should inform the doctor or nurse immediately if you think too much Retacrit has been injected.
Svojega zdravnika ali medicinsko sestro morate nemudoma obvestiti, če mislite, da Vam je bilo injicirano preveč zdravila Retacrit.
If you forget to use Retacrit
Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmere.
Do not use a double dose to make up for a forgotten dose.
Če ste prenehali uporabljati zdravilo Retacrit
If you stop using Retacrit Do not to stop the treatment without consultation of your doctor.
Zdravljenja ne prekinjajte brez posveta z zdravnikom.
Like all medicines, Retacrit can cause side effects, although not everybody gets them.
Kot vsa zdravila ima lahko tudi zdravilo Retacrit neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
189 – skin rash – flu-like symptoms, such as headache, aches and pains in the joints, feeling of weakness, tiredness, dizziness.
- gripi podobni simptomi, kot so glavobol, bolečine v sklepih, šibkost, utrujenost, omotica.
These may be more common at the start of treatment. – An increase in levels of blood platelets (thrombocytes) which are normally involved in the formation of a blood clot may occur.
- Pri bolnikih, ki se zdravijo z eritropoetinom, so poročali o žilnih in trombotičnih dogodkih
Your doctor will check on this. – Vascular and thrombotic events (blood clotting) in blood vessels, such as disturbed blood perfusion of the heart, heart attack, cerebral haemorrhages, stroke, temporary disturbance of blood perfusion in the brain, deep vein thrombosis, arterial thrombosis, pulmonary embolism, dilatation of the wall of a blood vessel (aneurysm), retinal thrombosis, and blood clot in an artificial kidney have been reported in patients receiving erythropoietin treatment. – Hypersensitivity reactions have been reported in rare cases, including swelling, mainly in the region of the eyelids and the lips (Quincke's oedema) and shock-like allergic reactions with symptoms of tingling, reddening, itching, hot flush and accelerated pulse. – Pure red cell aplasia (PRCA) has been very rarely reported in patients after months to years of subcutaneous (injection under the skin) erythropoietin treatment.
(krvni strdki) v krvnih žilah, kot so motnje krvnega pretoka v srce, srčna kap, možganske krvavitve, možganska kap, občasne motnje krvnega pretoka v možgane, globoka venska tromboza, arterijska tromboza, pljučna embolija, izbočenje žilne stene (anevrizma), retinalna tromboza in zamašitev umetne ledvice.
PRCA means the inability to produce enough red blood cells in the bone (see section “Take special care with Retacrit”).
- Poročali so o redkih primerih preobčutljivostnih reakcij, vključno z zatekanjem, predvsem okoli
Kidney patients – raised blood pressure which may require treatment with medicinal products or adjustment of the dosage of medicinal products you already take for high blood pressure.
vek in ustnic (Quinckejev edem), in alergičnih reakcijah, podobnih šoku, s simptomi ščemenja, rdečice, srbečice, vročinskih oblivov in pospešenega srčnega utripa.
Your doctor may monitor your blood pressure regularly while you are using Retacrit, particularly at the start of therapy. – Occlusion in the connection between artery and vein (shunt thrombosis) may occur especially if you have low blood pressure or if your arteriovenous fistula has complications.
- Redko so poročali so o pojavu čiste aplazije rdečih krvnih celic (PRCA) pri bolnikih, ki so se
Your doctor may check your shunt and prescribe a medicinal product to prevent thrombosis.
- Zvišan krvni tlak bo morda treba zdraviti z zdravili oziroma bo treba odmerek zdravil, ki ji
Cancer patients – blood clotting (thrombotic vascular events) (see section “Take special care with Retacrit”). – increase of blood pressure.
Zdravnik lahko med zdravljenjem z zdravilom Retacrit redno spremlja vaš krvni tlak, še posebej na začetku zdravljenja.
Therefore your haemoglobin-levels and your blood pressure should be controlled.
- Možna je obstrukcija spoja med arterijo in veno (tromboza šanta), še posebej, če imate nizek
HOW TO STORE RETACRIT
SHRANJEVANJE ZDRAVILA RETACRIT
Do not use Retacrit after the expiry date which is stated on the label and the carton.
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
Ask your pharmacist about how to dispose of medicines that are no longer required.
O načinu odstranjevanja zdravila, ki ga ne potrebujete več, se posvetujte s farmacevtom.
190 – The active substance is epoetin zeta (produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell line.
Zdravilna učinkovina je je epoetin zeta (pridobljen iz celične linije jajčnika kitajskega hrčka – (CHO – ” Chinese Hamster Ovary ”) s tehnologijo rekombinantne DNA.
Retacrit 1000 IU/0.3ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.3 ml solution for injection contains 1000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Retacrit 1. 000 i. e. / 0, 3 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 0, 3 ml raztopine za injiciranje vsebuje 1. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 2000 IU/0.6ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.6 ml solution for injection contains 2000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Retacrit 2. 000 i. e. / 0, 6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 0, 6 ml raztopine za injiciranje vsebuje 2. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 3000 IU/0.9ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.9 ml solution for injection contains 3000 international units (IU) epoetin zeta (recombinant human erythropoietin).
202 1 napolnjena injekcijska brizga z 0, 9 ml raztopine za injiciranje vsebuje 3. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 4000 IU/0.4ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.4 ml solution for injection contains 4000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Raztopina vsebuje 10. 000 i. e. epoetina zeta na ml.
The solution contains 10000 IU Epoetin zeta per ml.
Retacrit 5. 000 i. e. / 0, 5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 0, 5 ml raztopine za injiciranje vsebuje 5. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 5000 IU/0.5ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.5 ml solution for injection contains 5000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Raztopina vsebuje 10. 000 i. e. epoetina zeta na ml.
The solution contains 10000 IU Epoetin zeta per ml.
Retacrit 6. 000 i. e. / 0, 6 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 0, 6 ml raztopine za injiciranje vsebuje 6. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 6000 IU/0.6ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.6 ml solution for injection contains 6000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Raztopina vsebuje 10. 000 i. e. epoetina zeta na ml.
The solution contains 10000 IU Epoetin zeta per ml.
Retacrit 8. 000 i. e. / 0, 8 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 0, 8 ml raztopine za injiciranje vsebuje 8. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 8000 IU/0.8ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.8 ml solution for injection contains 8000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Raztopina vsebuje 10. 000 i. e. epoetina zeta na ml.
The solution contains 10000 IU Epoetin zeta per ml.
Retacrit 10. 000 i. e/ 1, 0 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 1, 0 ml raztopine za injiciranje vsebuje 10. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 20000 IU/0.5ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.5 ml solution for injection contains 20000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Retacrit 20. 000 i. e. / 0, 5 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 0, 5 ml raztopine za injiciranje vsebuje 20. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 30000 IU/0.75ml solution for injection in pre-filled syringe 1 pre-filled syringe with 0.75 ml solution for injection contains 30000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Retacrit 30. 000 i. e. / 0, 75 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 0, 75 ml raztopine za injiciranje vsebuje 30. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
Retacrit 40000 IU/1.0ml solution for injection in pre-filled syringe 1 pre-filled syringe with 1.0 ml solution for injection contains 40000 international units (IU) epoetin zeta (recombinant human erythropoietin).
Retacrit 40. 000 i. e. / 1, 0 ml raztopina za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga z 1, 0 ml raztopine za injiciranje vsebuje 40. 000 mednarodnih enot (i. e.) epoetina zeta * (rekombinantnega humanega eritropoetina).
191 The other ingredients are disodium phosphate dihydrate, sodium dihydrogen phosphate dihydrate, sodium chloride, calcium chloride dihydrate, polysorbate 20, glycine, leucine, isoleucine, threonine, glutamic acid, phenylalanine, water for injections, sodium hydroxide (pH adjuster), hydrochloric acid (pH adjuster).
Pomožne snovi so dinatrijev fosfat dihidrat, natrijev dihidrogen fosfat dihidrat, natrijev klorid, kalcijev klorid dihidrat, polisorbat 20, glicin, levcin, izolevcin, treonin, glutamatna kislina, fenilalanin, voda za injekcije, natrijev hidroksid (za prilagoditev pH), Klorovodikova kislina (za prilagoditev pH).
Retacrit is presented as a clear and colourless solution for injection in a pre-filled syringe with a fixed injection needle.
Napolnjena je v napolnjene injekcijske brizge s fiksno injekcijsko iglo.
The pre-filled syringes contain between 0.3 and 1.0 ml solution, depending on the content of epoetin zeta (see “What Retacrit contains”).
Vnaprej napolnjene brizge vsebujejo med 0, 3 in 1, 0 ml raztopine, odvisno od vsebnosti epoetin zeta (glejte "Kaj vsebuje zdravilo Retacrit").
One pack contains 1, 4 or 6 pre-filled syringes
Vsako pakiranje vsebuje 1, 4 do 6 vnaprej napolnjenih brizg.
Marketing Authorisation Holder
203 Imetnik dovoljenja za promet z zdravilom
Ireland Hospira Ireland Limited Tel: + 353 (0) 1 2962102
204 Slovenija Ireland Valentis Pharmaceuticals d. o. 0 Hospira Ireland Limited Tel: + 386 1 2000603 Tel: + 353 (0) 1 2962102
Desirudin is produced by a method known as ’ recombinant DNA technology’: it is made by a yeast that has received a gene (DNA), which makes it able to produce the substance.
Proizvede ga kvasovka, ki je prejela gen (DNA), kar ji omogoča izdelavo te snovi.